Bayer AG

Industry:	Pharmaceuticals, Drug Manufacturing & Research
Ranking:	Global 500
Revenues:	$47.5 Billion
Employees:	106,200

Description

Bayer AG is the management holding company for the Bayer Group. The Company’s business operations are organized into three groups: Bayer HealthCare, which is involved in the research, development and manufacture of health products for people and animals; Bayer CropScience, which is engaged in the crop protection and non-agricultural pest control, and Bayer MaterialScience, which supplies high-performance materials, such as polycarbonates and polyurethanes, and system solutions such as coatings, for a range of everyday uses. In November 2007, the Company suspended worldwide marketing of Trasylol. In October 2008, Bayer AG said that it had launched its new anticoagulant pill Xarelto in Britain and Germany.

Products & Services

chemical, pharmaceutical, drug, health care, life sciences

View More Statistics

Site Statistics

Monthly Unique Visitors:	934
Site Rank:	1,119,549
Trust Rating:	Neutral
Stats by

News Archive

Research from Bayer AG provides new data about chemical modeling. Chemicals & Chemistry; 7/3/2009 ...wrote B. Nisius and colleagues, Bayer AG. The researchers concluded: "The...information, contact U. Rester, Bayer AG, Corp. Development Innovat, Kaiser...Search Algorithm, Chemical Modeling, Bayer AG. This article was prepared by Chemicals... ...more

Bayer AG - Financial and Strategic Analysis Review. M2 Presswire; 6/29/2009 ...June 2009-Companies and Markets: Bayer AG - Financial and Strategic Analysis...M2 COMMUNICATIONS RDATE:29062009 Bayer AG - Financial and Strategic Analysis Review : New Company and Market Analysis Bayer AG - Financial and Strategic Analysis... ...more

Bayer AG - SWOT Framework Analysis. M2 Presswire; 12/11/2009 ...December 2009-Research and Markets: Bayer AG - SWOT Framework Analysis(C)1994...researchandmarkets.com/research/fdad36/bayer_ag_swot_fr) has announced the addition of the "Bayer AG - SWOT Framework Analysis" company... ...more